Triple therapy
Sponsors
The University of Hong Kong, Federal University of São Paulo, International Agency for Research on Cancer, University Hospital, Tours, Coordinación de Investigación en Salud, Mexico
Conditions
Acute Coronary SyndromeAtrial FibrillationAtrophic GastritisChoroidal NeovascularizationChronic GastritisCoronary Artery DiseaseDermatomyositis, Adult TypeDiabetes Mellitus, Type 2
Phase 1
Phase 3
Phase 4
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy
WithdrawnNCT01666236
Start: 2012-09-30End: 2014-09-30Updated: 2015-08-13
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
RecruitingNCT02047994
Start: 2013-03-31End: 2035-12-31Target: 30000Updated: 2025-05-02
Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens
CompletedNCT02395458
Start: 2013-03-31End: 2015-02-28Updated: 2015-03-23
APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF
CompletedNCT02789917
Start: 2016-06-30End: 2020-08-31Updated: 2020-08-14
A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection
CompletedNCT04076423
Start: 2019-10-10End: 2024-01-16Updated: 2024-10-01
Anti-inflammatory Status in DM2 Treated Patients
NCT04392557
Start: 2020-07-01End: 2021-06-20Target: 36Updated: 2020-09-16
Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis
NCT05375435
Start: 2022-01-01End: 2024-12-31Target: 120Updated: 2022-05-26
Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis
CompletedNCT07312721
Start: 2024-01-05End: 2024-12-30Updated: 2025-12-31
Unknown Phase
Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication
CompletedNCT01306786
Start: 2008-11-30End: 2011-02-28Updated: 2015-05-28
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
CompletedNCT02750631
Start: 2014-04-30End: 2017-07-31Updated: 2017-08-29
VCO Trial
Active, not recruitingPACTR201606001665364
Start: 2016-10-03Target: 60Updated: 2026-01-27
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
CompletedNCT02877199
Start: 2014-06-30End: 2015-04-30Updated: 2016-08-26
Ribavirin Bioavailability After Telaprevir Exposure
CompletedNCT02881034
Start: 2014-02-28End: 2015-02-28Updated: 2016-08-29
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
RecruitingNCT03365609
Start: 2017-09-20End: 2025-12-31Target: 1440Updated: 2025-02-28
Helicobacter pylori eradication in children
Active, not recruitingPACTR201807134057681
Start: 2018-08-01Target: 156Updated: 2026-01-27
Empirical vs Tailored Therapy for H. Pylori Infection
NCT04006340
Start: 2019-01-04End: 2019-08-31Target: 62Updated: 2019-07-05
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
NCT04113915
Start: 2019-11-30End: 2020-12-31Target: 150Updated: 2019-11-01
DIFFERENT REGIMENS FOR ERADICATION OF HELICOBACTER PYLORI INFECTION IN CHILDREN: A RANDOMIZED CONTROLLED TRIAL
Active, not recruitingPACTR202201686010590
Start: 2022-01-01Target: 200Updated: 2026-01-27